02035nas a2200409   4500000000100000008004100001260001300042653003900055653001500094653001000109653000900119653000900128653002100137653001300158653001100171653001100182653002200193653002300215653001100238653001800249653001200267653000900279653001600288653001800304653001500322653001800337100001500355700001400370700001300384700001400397700001500411245017700426300001100603490000800614520098900622022001401611       1994                            d  c1994 Oct10aAcquired Immunodeficiency Syndrome10aAdolescent10aAdult10aAged10aAsia10aCaribbean Region10aEthiopia10aEurope10aFemale10aHTLV-I Infections10aHTLV-II Infections10aHumans10aLatin America10aleprosy10aMale10aMiddle Aged10aNew York City10aPrevalence10aSouth America1 aGlaser J B1 aLevis W R1 aGruber T1 aCabrera A1 aPoiesz B J00aPrevalence of human T cell lymphotropic virus (HTLV) types I and II and human immunodeficiency virus type 1 infections among persons with Hansen's disease in New York City.  a1007-90 v1703 a<p>One-hundred seven consecutive patients attending a New York Hansen's disease clinic from November 1990 through June 1991 were tested for retroviruses. This cohort included 58 patients diagnosed with Hansen's disease after the onset of the AIDS epidemic, 54 of whom immigrated to the United States before diagnosis of Hansen's disease (median, 7 years). The overall rate (1.9%) of human T cell lymphotropic virus (HTLV) type I infection was low. Two (3.6%) of 55 Caribbean-born patients had polymerase chain reaction (PCR)-documented HTLV-I infection, but this incidence was not higher than expected in persons without Hansen's disease. No patient had PCR-documented evidence of either HTLV-II or human immunodeficiency virus (HIV) type 1 infection. The low rate of HIV-1 among those studied was likely related to an absence of classic HIV risk behavior because about half of the cohort could have incubated Mycobacterium leprae for a prolonged period while infected with HIV-1.</p>  a0022-1899